Synektik S.A.

Cardiovascular imaging

Clinical research is centered on coronary artery disease and the use of positron emission tomography to improve detection of clinically significant coronary narrowing in people with suspected disease.

  • Myocardial perfusion imaging
  • Coronary artery disease diagnosis
  • Cardiac PET tracers

The sponsor’s work in this area focuses on imaging-based assessment of cardiac blood flow and ischemic heart disease.

Quantitative myocardial blood flow

Research activity includes absolute myocardial blood flow measurement and validation of PET-derived flow metrics for human cardiac imaging, with emphasis on quantitative analysis of perfusion.

  • Dynamic PET imaging
  • Flow quantification
  • Reference flow comparison

This area supports the assessment of coronary circulation using quantitative imaging endpoints.

Radiotracer development

The sponsor is involved in the clinical evaluation of a novel fluorine-18-labelled imaging agent for cardiac PET applications in suspected coronary artery disease.

  • 18F-labelled tracer
  • Molecular imaging
  • Diagnostic radiopharmaceuticals

Its research interest extends to imaging agents designed for clearer visualization of myocardial perfusion and coronary pathology.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

    Recruiting

    1 1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland Germany Italy The Netherlands Poland
  • Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland